OverviewSuggest Edit

Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company's products serve the specialized needs of orthopedic and neurological surgeons, including ortho biologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.

TypePublic
Founded2006
HQBelgrade, US
Websitextantmedical.com
Employee Ratings2.4

Latest Updates

Employees (est.) (Dec 2019)141(-15%)
Revenue (FY, 2019)$64.7 M(-10%)
Share Price (Jul 2020)$1.1 (+2%)
Cybersecurity ratingAMore

Key People/Management at Xtant Medical

Kevin Brandt

Kevin Brandt

Sr. Vice President and Chief Commercialization Officer

Xtant Medical Office Locations

Xtant Medical has offices in Belgrade and Miamisburg
Belgrade, US (HQ)
664 Cruiser Ln
Miamisburg, US
452 Alexandersville Rd
Show all (2)

Xtant Medical Financials and Metrics

Xtant Medical Revenue

Embed Graph
View revenue for all periods
Xtant Medical's revenue was reported to be $64.68 m in FY, 2019
USD

Revenue (Q1, 2020)

14.8m

Gross profit (Q1, 2020)

9.6m

Gross profit margin (Q1, 2020), %

65%

Net income (Q1, 2020)

(2.5m)

EBIT (Q1, 2020)

(1.4m)

Market capitalization (31-Jul-2020)

14.1m

Closing stock price (31-Jul-2020)

1.1

Cash (31-Mar-2020)

3.2m

EV

90.3m
Xtant Medical's current market capitalization is $14.1 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

29.7m33.0m33.1m35.3m59.3m90.0m82.6m72.2m64.7m

Revenue growth, %

7%68%52%

Cost of goods sold

9.1m10.3m14.2m13.0m20.3m27.7m32.5m28.7m22.2m

Gross profit

20.5m22.6m18.9m22.3m39.1m62.3m50.1m43.5m42.5m
Quarterly
USDQ2, 2011

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

2.2 x
Show all financial metrics

Xtant Medical Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Xtant Medical Online and Social Media Presence

Embed Graph

Xtant Medical News and Updates

Xtant Medical Announces Fourth Quarter and Full Year 2019 Financial Results

BELGRADE, Mont., March 05, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended Dece…

Xtant Medical to Feature Innovative Product Offering at the CNS Annual Meeting

BELGRADE, Mont., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, will feature its recently announced Intice™-C Titanium Cervical Interbody Spacer, Atrix-C …

Xtant Medical Showcases Continued Innovation with Three New Product Introductions at NASS 2019

BELGRADE, Mont., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, plans to introduce three new products at the North American Spine Society (NASS) 2019 Ann…

Xtant Medical Announces Second Quarter 2019 Financial Results

BELGRADE, Mont., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2019.

Xtant Medical Announces First Quarter 2019 Financial Results

BELGRADE, Mont., May 15, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2019.

Xtant Medical Receives Noncompliance Notice from NYSE American

BELGRADE, Mont., April 05, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced receipt of notification from the NYSE American that the Company is not in…
Show more

Xtant Medical Blogs

Xtant Medical Names Sean Browne President and Chief Executive Officer

BELGRADE, Mont. , Oct. 07, 2019 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Sean Browne as President and Chief Executive Officer, The…

Xtant Medical to Issue Second Quarter 2019 Financial Results on August 8, 2019

The post Xtant Medical to Issue Second Quarter 2019 Financial Results on August 8, 2019 appeared first on Xtant Medical.

Xtant Medical Announces NYSE American Acceptance of Plan to Regain Compliance with Continued Listing Standards

BELGRADE, Mont. , May 28, 2019 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that NYSE Regulation has accepted the Company’s plan to regain compliance The…

Xtant Medical to Issue First Quarter 2019 Financial Results on May 15, 2019

BELGRADE, Mont. , May 08, 2019 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended The po…

Xtant Medical Announces Appointment of Chief Operations Officer

BELGRADE, MT , Jan. 11, 2019 (GLOBE NEWSWIRE) — Xtant Medical Holdings , Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Ronald Berlin as Vice President & Chief Operations The …

Xtant Medical Announces Appointment of Chief Financial Officer

BELGRADE, MT, Aug. 20, 2018 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development and commercialization of regenerative medicine products and medical devices, today announced the appointment of Kathie Lenzen as chief financial officer, effective August 20…
Show more

Xtant Medical Frequently Asked Questions

  • When was Xtant Medical founded?

    Xtant Medical was founded in 2006.

  • Who are Xtant Medical key executives?

    Xtant Medical's key executives are Kevin Brandt.

  • How many employees does Xtant Medical have?

    Xtant Medical has 141 employees.

  • What is Xtant Medical revenue?

    Latest Xtant Medical annual revenue is $64.7 m.

  • What is Xtant Medical revenue per employee?

    Latest Xtant Medical revenue per employee is $458.7 k.

  • Who are Xtant Medical competitors?

    Competitors of Xtant Medical include Boston Scientific, XENAMED Industries and Deltex Medical.

  • Where is Xtant Medical headquarters?

    Xtant Medical headquarters is located at 664 Cruiser Ln, Belgrade.

  • Where are Xtant Medical offices?

    Xtant Medical has offices in Belgrade and Miamisburg.

  • How many offices does Xtant Medical have?

    Xtant Medical has 2 offices.